 |
|
Mutation in the Gene Responsible for Cystic Fibrosis and Predisposition to Chronic Rhinosinusitis in the General Population
XinJing Wang, MD, PhD;
Birgitta Moylan;
Donald A. Leopold, MD;
Jean Kim, MD, PhD;
Ronald C. Rubenstein, MD, PhD;
Alkis Togias, MD;
David Proud, PhD;
Pamela L. Zeitlin, MD, PhD;
Garry R. Cutting, MD
JAMA. 2000;284:1814-1819.
Context Chronic rhinosinusitis (CRS) is a common condition in the US general population, yet little is known about its underlying molecular cause. Chronic rhinosinusitis is a consistent feature of the autosomal recessive disorder cystic fibrosis (CF).
Objective To determine whether mutations in the cystic fibrosis transmembrane regulator (CFTR) gene, which is responsible for CF, predispose to CRS.
Design Case-control study conducted from 1996 to 1999 in which the DNA of CRS patients and controls was typed for 16 mutations that account for 85% of CF alleles in the general population. Chronic rhinosinusitis patients with 1 CF mutation were evaluated for a CF diagnosis by sweat chloride testing, nasal potential difference measurement, and DNA analysis for additional mutations.
Setting Otolaryngology–head and neck clinic of a US teaching hospital.
Participants One hundred forty-seven consecutive adult white patients who met stringent diagnostic criteria for CRS and 123 CRS-free white control volunteers of similar age range, geographic region, and socioeconomic status.
Main Outcome Measures Presence of CF mutations by DNA analysis among CRS patients vs controls.
Results Eleven CRS patients were found to have a CF mutation ( F508, n = 9; G542X, n = 1; and N1303K, n = 1). Diagnostic testing excluded CF in 10 of these patients and led to CF diagnosis in 1. Excluding this patient from the analyses, the proportion of CRS patients who were found to have a CF mutation (7%) was significantly higher than in the control group (n = 2 [2%]; P = .04, both having F508 mutations). Furthermore, 9 of the 10 CF carriers had the polymorphism M470V, and M470V homozygotes were overrepresented in the remaining 136 CRS patients (P = .03).
Conclusion These data indicate that mutations in the gene responsible for CF may be associated with the development of CRS in the general population.
Author Affiliations: McKusick-Nathans Institute of Genetic Medicine (Drs Wang and Cutting), Department of Medicine (Drs Togias and Proud and Ms Moylan), Department of Otolaryngology–Head and Neck Surgery (Drs Leopold and Kim), and Department of Pediatrics (Drs Rubenstein, Zeitlin, and Cutting), Johns Hopkins University School of Medicine, Baltimore, Md. Dr Rubenstein is now affiliated with the Department of Pulmonary Medicine, Children's Hospital of Philadelphia, Philadelphia, Pa.
RELATED ARTICLES
October 11, 2000
JAMA. 2000;284(14):1863-1864.
EXTRACT
| FULL TEXT
Cystic Fibrosis
JAMA. 2000;284(14):1884.
PDF
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Heterozygosity for a Single Mutation in the ABCC6 Gene May Closely Mimic PXE: Consequences of This Phenotype Overlap for the Definition of PXE
Martin et al.
Arch Dermatol 2008;144:301-306.
ABSTRACT
| FULL TEXT
Prospective analysis of cystic fibrosis transmembrane regulator mutations in adults with bronchiectasis or pulmonary nontuberculous mycobacterial infection.
Ziedalski et al.
Chest 2006;130:995-1002.
ABSTRACT
| FULL TEXT
Mutations in the Cystic Fibrosis Transmembrane Regulator Gene and In Vivo Transepithelial Potentials
Wilschanski et al.
Am. J. Respir. Crit. Care Med. 2006;174:787-794.
ABSTRACT
| FULL TEXT
Increased prevalence of interleukin-1 receptor antagonist gene polymorphism in patients with chronic rhinosinusitis.
Cheng et al.
Arch Otolaryngol Head Neck Surg 2006;132:285-290.
ABSTRACT
| FULL TEXT
A Haplotype Framework for Cystic Fibrosis Mutations in Iran
Elahi et al.
J. Mol. Diagn. 2006;8:119-127.
ABSTRACT
| FULL TEXT
ABCA3 Mutations Associated with Pediatric Interstitial Lung Disease
Bullard et al.
Am. J. Respir. Crit. Care Med. 2005;172:1026-1031.
ABSTRACT
| FULL TEXT
Dynamic Activation of Cystic Fibrosis Transmembrane Conductance Regulator by Type 3 and Type 4D Phosphodiesterase Inhibitors
Liu et al.
J. Pharmacol. Exp. Ther. 2005;314:846-854.
ABSTRACT
| FULL TEXT
Chloride Transport in Nasal Ciliated Cells of Cystic Fibrosis Heterozygotes
Sermet-Gaudelus et al.
Am. J. Respir. Crit. Care Med. 2005;171:1026-1031.
ABSTRACT
| FULL TEXT
Increased Prevalence of Chronic Rhinosinusitis in Carriers of a Cystic Fibrosis Mutation
Wang et al.
Arch Otolaryngol Head Neck Surg 2005;131:237-240.
ABSTRACT
| FULL TEXT
Establishing a diagnosis of cystic fibrosis
Southernl and Peckham
Chronic Respiratory Disease 2004;1:205-210.
ABSTRACT
Clinical Manifestations of Cystic Fibrosis Among Patients With Diagnosis in Adulthood
Gilljam et al.
Chest 2004;126:1215-1224.
ABSTRACT
| FULL TEXT
Interleukin 8 Secretion from Monocytes of Subjects Heterozygous for the {Delta}F508 Cystic Fibrosis Transmembrane Conductance Regulator Gene Mutation Is Altered
Zaman et al.
CVI 2004;11:819-824.
ABSTRACT
| FULL TEXT
Association of Cystic Fibrosis with Abnormalities in Fatty Acid Metabolism
Freedman et al.
NEJM 2004;350:560-569.
ABSTRACT
| FULL TEXT
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
Gibson et al.
Am. J. Respir. Crit. Care Med. 2003;168:918-951.
ABSTRACT
| FULL TEXT
A haplotype-based molecular analysis of CFTR mutations associated with respiratory and pancreatic diseases
Lee et al.
Hum Mol Genet 2003;12:2321-2332.
ABSTRACT
| FULL TEXT
Chronic pancreatitis and cystic fibrosis
Witt
Gut 2003;52:ii31-41.
ABSTRACT
| FULL TEXT
Population Screening in the Age of Genomic Medicine
Khoury et al.
NEJM 2003;348:50-58.
FULL TEXT
Variant Cystic Fibrosis Phenotypes in the Absence of CFTR Mutations
Groman et al.
NEJM 2002;347:401-407.
ABSTRACT
| FULL TEXT
|
